SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become more
customer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions WHITEPAPER DOWNLOAD
Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all. BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & Market Access USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become more customer-centric.
EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions WHITEPAPER DOWNLOAD
Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all. BE THE FIRST TO READ THE FULL WHITEPAPER eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & Market Access USA 2016.
EYEFORPHARMA
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditionsTerms and conditions GET THE BRIEFING NOW eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions GET YOUR FREE COPY TODAY Download eyeforpharma’s latest industry whitepaper featuring key contributions from Astellas, Takeda and AstraZeneca including:. Exclusive results from the “DTC Attitudes, Behaviours and Preferences” study- what do patients think about DTC? How listening to patient needs and involving them in the design of advertising is winning champions and delivering results DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> DOWNLOAD YOUR BROCHURE NOW eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions DOWNLOAD THE BROCHURE NOW James Mackintosh Global Project Director jmackintosh@eyeforpharma.com +44 (0)207 375 7163 : Ben Parkes Head of Product bparkes@eyeforpharma.com DOWNLOAD THE BROCHURE NOW: “Loyalty is incredibly profitable,” says customer experience specialist and former Customer Experience Lead for Pfizer Europe, Mike Bellis. “Creating loyalty means you don’t have to work so hard to sell, improving your operational efficiency and profit margins. ENTER YOUR DETAILS HERE TO DOWNLOAD eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions DOWNLOAD YOUR BROCHURE eyeforpharma Barcelona is the only place to be for 2016. The global event brings together leading pharma executives to share how you can address the era of customer and patient empowerment. PRE-ORDER THE BROCHURE NOW Without evidence, there can be no access – that’s why 150 of America’s most forward-thinking pharma execs in the managed markets, pricing, HEOR, analytics and data space are attending RWE & Market Access USA 2016.
SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. SEE THE AGENDA AND THE SPEAKER LINE-UP, DOWNLOAD THE eyeforpharma is a trading name of FC Business Intelligence Ltd. Registered in England and Wales no.4388971. Registered address 7-9 Fashion Street, London, E1 6PX, UK | Terms and conditions DOWNLOAD YOUR EXCLUSIVE 24 PAGE WHITEPAPER BELOW GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to deliver results in the long-term. EVERYTHING YOU NEED TO KNOW ABOUT THE CHANGING MEDICAL The expert panel of contributors includes: Dr Ameet Nathwani, Chief Medical Officer, Sanofi Antonio Tataranni, SVP and Head of Medical Affairs, Sanofi Danie Du Plessis, Head of Medical Affairs, GlaxoSmithKline Gundula Schneidewind, VP, Medical Affairs, Takeda Michael Zaiac, Head of Medical Affairs, Celgene Mark Rees Saunders, MSL Excellence Lead, AstraZeneca DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. GET YOUR FREE COPY TODAY Goodbye, Sales and Marketing. Hello, integrated Commercial team! This in-depth eyeforpharma whitepaper will explore how pharma is integrating customer-facing teams in order to become more customer-centric.
DOWNLOAD YOUR EXTRACT Aleksandra Sledzinska On Demand Global Account Manager eyeforpharma On Demand +44 (0) 20 7375 4332 US toll free: 1800 814 3459 ex: 4332 asledzinska@eyeforpharma.com DOWNLOAD THE BROCHURE NOW: At eyeforpharma Philadelphia 2018 we encourage the most inspiring and forward-thinking leaders from our industry to share their ideas, lessons learnt and case studies on how they have turned insights from patients and customers into genuine healthcare innovations. DOWNLOAD YOUR FREE COPY OF THE WHITE PAPER HERE! Medical Affairs is undergoing a revolution. A new Medical model is therefore top priority across pharma’s leadership. With the help of Allergan, Takeda, Roche, Eisai, Ipsen and many more our latest white paper explores the newest approaches to succeeding in Medical’s mission. Download your free copy of the white paper here >>> LOGIN
Username or e-mail * Password *
* Forgotten Password? Subscribe
| Forgot your password? Close log in window __ * On Demand |
* Newsletter |
* Log in
Clinical eyeforpharma Thought leadership and innovation for the Pharmaceutical Industry Search this site
* Home
* Topics
* Commercial
* Access and Evidence * Clinical
* Patients and Medical * Research
* Reports
* Custom White Papers * Conference Slides, Videos, Audio * Webinars
* Reports
* Events
* On Demand
* What is On Demand? * Subscribe
* Free Trial
* About/contact
* Contact Us
* Management Team
Menu __
Moving remote: the post-pandemic clinical trial Pharma is rapidly adapting its approach to trials in the face of the pandemic and there is great opportunity for far reaching improvements once this is all over Access and Evidence
EYEFORPHARMA GOES VIRTUAL To safeguard the health of participants, the physical events of eyeforpharma Barcelona and eyeforpharma Philadelphia will not go ahead....
Multichannel
COVID-19 IS ACCELERATING DIGITAL TRANSFORMATION No one in pharma needs to be told that COVID-19 is upending business as we know it. But in the face of this unprecedented change...
LATEST
*
Patients and Medical HOW SHOULD PHARMA APPROACH PATIENT COLLABORATION IN THE 2020S? Lucy Fulford , (Apr 1, 2020)
Deeper, more holistic, strategic and ‘patient directed’ engagement will be a win for all this coming decade *
Multichannel
COVID-19 IS ACCELERATING DIGITAL TRANSFORMATION Andrew Stone , (Apr 1, 2020) Digital capabilities are proving their worth in the face of the sudden upheavals driven by the pandemic and ongoing investment will pay dividends, says Bertrand Bodson, Novartis CDO *
Medical
LEADING THE HUNT FOR A COVID-19 VACCINE Andrew Stone , (Apr 1, 2020) J&J gives the inside track on the search for a COVID-19 vaccine at eyeforpharma’s Barcelona conference *
Commercial
VIRTUAL TRADE SHOW BEST PRACTICES: INTELLIGENT MEDICAL OBJECTS AND HIMSS
Paul Schrimpf , (Mar 28, 2020) A new way of thinking and acting is needed for virtual marketing in the post COVID-19 world, says Paul Schrimpf of management consultant Prophet
*
Patients and Medical PATIENTS AND RWE: IS THIS THE YEAR? Tom Disley , (Mar 26, 2020) There is reason to hope that the long-awaited breakthroughs flowing from patient-generated data are about to happen More Content
MOST POPULAR
Towards the sales force of the near future Andrew Stone , (Mar 4, 2020) Blending the digital and the personal can transform engagement, focus sales activity and help meet HCPs’ fast evolving needs if done right Advancing through partnerships Andrew Stone , (Mar 14, 2020) Collaboration makes sense on many fronts on our journey to sustainably improve the lives of patients, says Merck’s Chris Round Evolving HTA frameworks to accelerate innovation Andrew Stone , (Mar 14, 2020) Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague OPINION
eyeforpharma Awards: Recognizing and celebrating innovation Paul Simms , (Dec 19, 2019) Celebrating winners makes genuine innovation visible, setting the bar higher and broadening the possibilities for pharma by showing what can be achieved
The Jan Twomey story — Empowering and connecting Jill Donahue , (Sep 6, 2019) Up Close and Personal with Jan Twomey, MD, Medical Director, Takeda Oceania
More Columns
COMMERCIAL
*
VIRTUAL TRADE SHOW BEST PRACTICES: INTELLIGENT MEDICAL OBJECTS AND HIMSS
Paul Schrimpf , (Mar 28, 2020) A new way of thinking and acting is needed for virtual marketing in the post COVID-19 world, says Paul Schrimpf of management consultant Prophet
*
THE CHANGING NATURE OF PHARMA SALES: A CONVERSATION ON MANY LEVELS Ulrich Neumann , (Feb 20, 2020) The new approach to sales marries state of the art analytics with a classical approach to engagement *
TIME TO EMBRACE SOCIAL MEDIA Katie Osborne , (Feb 4, 2020) Patients are turning to social media as never before and pharma needs to catch up
*
HAS DIRECT TO CONSUMER MARKETING IN PHARMA HAD ITS DAY? Lucy Fulford , (Nov 25, 2019) Outmoded and cliched DTC campaigns may be harming not helping pharma in the US
*
BREAKING OUT OF DATA SILOS IN COMMERCIAL Ulrich Neumann , (Oct 21, 2019) Pharma’s commercial teams have much to gain if they can overcome technical and cultural blockages that prevent data sharing More Commercial
ACCESS AND EVIDENCE
*
EVOLVING HTA FRAMEWORKS TO ACCELERATE INNOVATION Andrew Stone , (Mar 14, 2020) Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague *
CAN WE AFFORD TO PAY FOR FUTURE CURES? Ulrich Neumann , (Jan 24, 2020) Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging *
ADVANCING RWE TOGETHER WITH ACADEMIA Katie Osborne , (Jan 2, 2020) Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust *
PUTTING A PRICE ON LIFE: IS THE ANSWER OUTSIDE PHARMA? Nicola Davies , (Nov 4, 2019) Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthcare advancements suggests maybe not. *
PUTTING THE I IN PILLS Izzy Gladstone , (Jun 27, 2019) Individualised medicine has so far failed to live up to the hype but innovations in the field are on the cusp of disrupting the way pharma and healthcare develop and provide treatments. More Market Access
PATIENTS AND MEDICAL *
HOW SHOULD PHARMA APPROACH PATIENT COLLABORATION IN THE 2020S? Lucy Fulford , (Apr 1, 2020)
Deeper, more holistic, strategic and ‘patient directed’ engagement will be a win for all this coming decade *
PATIENTS AND RWE: IS THIS THE YEAR? Tom Disley , (Mar 26, 2020) There is reason to hope that the long-awaited breakthroughs flowing from patient-generated data are about to happen *
ADVANCING THROUGH PARTNERSHIPS Andrew Stone , (Mar 14, 2020) Collaboration makes sense on many fronts on our journey to sustainably improve the lives of patients, says Merck’s Chris Round *
ONLINE HOSPITALS – THE JOURNEY FROM EAST TO WEST Katie Osborne , (Mar 13, 2020) Artificial intelligence and digital are already transforming medical service delivery in China and it’s heading west rapidly *
BUILDING AN INNOVATION CULTURE Andrew Stone , (Mar 12, 2020) Without the right approach to risk and culture, pharma may miss the big opportunities, says Bayer’s Sebastian Guth More Patients and Medical LATEST VIDEOS
__ Cue Biopharma: Diagnostic & disease detection to transform biopharma
__ Dr Avi Spira: Janssen's use of new technology to intercept lung cancer
__ The Eisenbahnscheinbewegung Risk __ Act like SARS and go viral with patient centricity __ CEO of LEO Pharma on how they are driving collaborations UPCOMING EVENTS
*
EYEFORPHARMA BARCELONA VIRTUAL _March 30 - April 3_ *
Commercial Strategy
*
Digital & Marketing
*
Real-World Evidence
*
Market Access
*
Medical Affairs
*
Patient Engagement
*
Digital Therapeutics *
Digital Clinical Trials *
EYEFORPHARMA PHILADELPHIA VIRTUAL _April 14-17_
*
Digital & Marketing
*
Commercial Excellence & Sales *
Patient Engagement
*
Digital Clinical Trials *
Market Access
*
RWE & Data Science
*
Medical Affairs
*
The Innovation Stag
e
*
14TH ANNUAL EYEFORPHARMA JAPAN _May 26 - 27_
*
Commercial Excellence *
RWE & Medical
*
Clinical Innovation
*
EYEFORPHARMA MARKETING DISRUPTION SUMMIT _October 6-7, Philadelphia_ *
Commercial
*
Marketing and Digital *
Data
*
EYEFORPHARMA PATIENT SUMMIT USA _October 6-7 Philadelphia_ *
EYEFORPHARMA MARKETING AND CUSTOMER INNOVATION EUROPE _October 15-16, London_ *
Commercial
*
Marketing and Digital *
Data
*
EYEFORPHARMA PATIENT SUMMIT EUROPE _October 15-16, London_ *
EYEFORPHARMA AWARDS EUROPE _November 5, Amsterdam_ *
EYEFORPHARMA AWARDS USA _December 9, Philadelphia_ IN-DEPTH ANALYSIS
*
Defragmenting Data for the Future of Pharma R&D *
Pharma’s Transformation through Automation *
Digital Therapeutics: pharma’s threat or opportunity *
Agility: How Pharma Can Be Bolder, Faster, Better *
Authenticity: Pharma’s New Currency *
Trends in Access Europe RECENT PRESS RELEASES *
eyeforpharma, a division of Reuters Events, announces eyeforpharma Philadelphia 2020 is now a virtual event *
Where pharma comes to life: Join 2000+ attendees at eyeforpharma Barcelona 2020
*
eyeforpharma Philadelphia 2020: Become healthcare's solution *
Top Business Hub for Pharmaceutical Leaders Announces Prestigious Multi-Company Collaboration To Create A Global Standard of "Good Patient Practice"
More Press Releases
eyeforpharma is a registered company in England and Wales - Registered number 09823909. 7-9 Fashion Street, London, E1 6PX, UK. eyeforpharma 2020 | PATIENT POLICY | LEGAL NOTICE | TERMS & CONDITIONS | +44 (0) 207 375 7222 | PRIVACY POLICY
Follow
Hide
Follow on Twitter
Twitter
Follow on LinkedIn
LinkedIn
Follow on YouTube
YouTube
Follow on RSS
RSS
Show
Close
AddThis
